← Open Payments lookup

AMANDA WILHITE: Open Payments

NPI 1124367362 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$70,764 in 192 payments from 10 companies in 2025. Trend: 2023 $36,699 · 2024 $48,772 · 2025 $70,764

Speaker / faculty: $51,226Travel & lodging: $11,763Consulting: $4,146Food & beverage: $2,885Honoraria: $744
CompanyPaymentsAmount
Janssen Biotech, Inc.72$43,496
ABBVIE INC.71$12,576
Lilly USA, LLC15$8,849
PFIZER INC.21$4,364
Celltrion USA Inc.5$1,280
GENZYME CORPORATION3$85
Regeneron Healthcare Solutions, Inc.2$50
Takeda Pharmaceuticals U.S.A., Inc.1$29
CSL Behring1$21
Salix Pharmaceuticals, a division of Bausch Health US, LLC1$14

Products named: TREMFYA, SKYRIZI, OMVOH, VELSIPITY, STELARA, ZYMFENTRA, RINVOQ, XELJANZ.

Industry payments across TX — which companies pay providers there.